These findings demonstrate that the GR/NF‐κB interaction is not a static process of simple repression but a dynamic co‐regulation that is highly dependent on the cellular context, reinforcing the complexity of this signaling axis in cancer pathology. The gene discussed is NFKB1; the disease is cancer.